Chemoinformaics analysis of Z,Z-2,15-Octadecedien-1-ol acetate
| Molecular Weight | 308.506 | nRot | 15 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 0 |
| Exact Molecular Weight | 308.272 | nRing | 0 |
| Solubility: LogS | -5.84 | nHRing | 0 |
| Solubility: LogP | 6.498 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 59.0085 |
| nHD | 0 | BPOL | 38.7195 |
| QED | 0.425 |
| Synth | 2.253 |
| Natural Product Likeliness | 0.749 |
| NR-PPAR-gamma | 0.315 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.101 |
| HIA | 0.004 |
| CACO-2 | -4.652 |
| MDCK | 0.0000163 |
| BBB | 0.216 |
| PPB | 0.975169 |
| VDSS | 1.779 |
| FU | 0.0189886 |
| CYP1A2-inh | 0.462 |
| CYP1A2-sub | 0.208 |
| CYP2c19-inh | 0.388 |
| CYP2c19-sub | 0.071 |
| CYP2c9-inh | 0.16 |
| CYP2c9-sub | 0.958 |
| CYP2d6-inh | 0.051 |
| CYP2d6-sub | 0.082 |
| CYP3a4-inh | 0.169 |
| CYP3a4-sub | 0.055 |
| CL | 5.502 |
| T12 | 0.155 |
| hERG | 0.153 |
| Ames | 0.008 |
| ROA | 0.016 |
| SkinSen | 0.932 |
| Carcinogencity | 0.039 |
| EI | 0.959 |
| Respiratory | 0.553 |
| NR-Aromatase | 0.026 |
| Antiviral | No |
| Prediction | 0.540101 |